Email galleryPricing
Get started
Sign InGet started
Email gallery/Brands/Merck KGaA
MK

Merck KGaA

Pharmaceuticalsemdgroup.com12 emails captured, the last on Sep 21, 2026

Migma AI designs one like these with your logo, colors, and images.

July to September 2026 5 emails

Computational Chemistry and AI in Chemistry Conference at Merck in Darmstadt email from Merck KGaA

Computational Chemistry and AI in Chemistry Conference at Merck in Darmstadt

Sep 21, 2026

Merck Delivers Robust Q2 2026 Performance, Upgrades Full-Year Guidance email from Merck KGaA

Merck Delivers Robust Q2 2026 Performance, Upgrades Full-Year Guidance

Aug 6, 2026

Merck Opens BioReliance® Facility in Darmstadt to Support Drug Product Release in Europe email from Merck KGaA

Merck Opens BioReliance® Facility in Darmstadt to Support Drug Product Release in Europe

Jul 16, 2026

European Commission Approves Erbitux® (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation email from Merck KGaA

European Commission Approves Erbitux® (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation

Jul 14, 2026

Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations email from Merck KGaA

Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations

Jul 8, 2026

May to June 2026 7 emails

Merck Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets email from Merck KGaA

Merck Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Jun 25, 2026

Merck Announces Healthcare Leadership Changes for Global Commercial Strategy and North America email from Merck KGaA

Merck Announces Healthcare Leadership Changes for Global Commercial Strategy and North America

Jun 24, 2026

Merck Announces Hiba Therapeutics as Winner of 2026 North American Advance Biotech Grant email from Merck KGaA

Merck Announces Hiba Therapeutics as Winner of 2026 North American Advance Biotech Grant

Jun 24, 2026

Merck Collaborates with Versant Ventures to Launch Saturnus Bio email from Merck KGaA

Merck Collaborates with Versant Ventures to Launch Saturnus Bio

Jun 23, 2026

2026 Future Insight Prize Goes to Spear’s Vasilis Ntziachristos email from Merck KGaA

2026 Future Insight Prize Goes to Spear’s Vasilis Ntziachristos

Jun 23, 2026

Merck Appoints New Heads of Discovery Solutions and Strategy & BD for Life Science email from Merck KGaA

Merck Appoints New Heads of Discovery Solutions and Strategy & BD for Life Science

Jun 8, 2026

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer email from Merck KGaA

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer

May 21, 2026

Explore styles used by Merck KGaA

  • Corporate
  • Text Heavy
  • Electronics & Tech
  • Awareness
  • Newsletter Subscribers
  • Newsletter
  • Business & B2B Retail
  • Monthly Highlights
  • Retention
  • Consideration

Solutions

  • Marketers
  • Designers
  • Developers
  • Enterprise
  • Claude
  • ChatGPT
  • Grok Bot

Resources

  • Countdowns
  • Spoof checker
    New
  • BIMI logo
  • Email gallery
  • Tabpass
  • Pricing
  • Docs
  • Blog

Company

  • About Us
  • Brand guidelines
  • Brand kit
  • Careers
  • Support
  • FAQ

Legal

  • Privacy Policy
  • Terms & Conditions
  • Do not sell or share my personal information
  • Copyright Notice & Takedown
  • Data Processing Agreement
  • Acceptable Use

Socials

  • X / Twitter
  • Discord
  • YouTube
  • LinkedIn
MigmaAI
© 2026 MigmaAI, Inc. All rights reserved.
Backed byEWOR Logo DarkEWOR Logo Light
Built with ❤️ in Stockholm & Barcelona

Emails similar to Merck KGaA

Explore other emails with shared design, campaign, or industry tags.

Reining in AI | Kansas City's Meetings Investments email from Northstar Meetings Group
NMNorthstar Meetings Group

Reining in AI | Kansas City's Meetings Investments

Pulse Check: What a trio of surveys tells us about climate action in Canada email from Royal Bank of Canada
Royal Bank of Canada logoRoyal Bank of Canada

Pulse Check: What a trio of surveys tells us about climate action in Canada

The Design Choices That Lower Burnout for Hospital Staff email from Gensler
Gensler logoGensler

The Design Choices That Lower Burnout for Hospital Staff

Energy innovations, Egypt's next chapter, powering the transition email from World Economic Forum
WEWorld Economic Forum

Energy innovations, Egypt's next chapter, powering the transition

Cyber Daily: United to block customers from using AI agents, citing cyber threats email from Recorded Future
Recorded Future logoRecorded Future

Cyber Daily: United to block customers from using AI agents, citing cyber threats

Perspectives: Investing in Technology for Your Association’s Future email from Smithbucklin
SSmithbucklin

Perspectives: Investing in Technology for Your Association’s Future

The most expensive affair in history? email from The Economist
The Economist logoThe Economist

The most expensive affair in history?

SANS NewsBites Vol. 28 Num. 85 : Microsoft Outage; N-able N-central Taken Offline After Multiple Vulnerability Disclosures; ConnectWise ScreenConnect Breaches Under Investigation email from SANS Institute
SISANS Institute

SANS NewsBites Vol. 28 Num. 85 : Microsoft Outage; N-able N-central Taken Offline After Multiple Vulnerability Disclosures; ConnectWise ScreenConnect Breaches Under Investigation